Skip to main content

Coronavirus (COVID-19) Updates: Visitation Policies (New! 11.25.20) | How We're Keeping You Safe | Latest COVID Information

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

UGYO17017 / MD Andersen / Richard Moore

Research Question:
Can the blood test, CA-125 be helpful in the early detection of ovarian cancer in women who are at low risk?

Basic Study Information

Purpose:
The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT00539162?term=ID01-022&rank=1
Study Reference #: UGYO17017

Lead Researcher (Principal Investigator)

Lead Researcher:  Richard Moore

Study Contact Information

Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu

Additional Study Details

Return to Search